United States Pharmaceuticals

Medicus Pharma Ltd (MDCX)

Track

Track

Medicus Pharma Ltd has recorded no insider trading activity within the past three months. The most recent transactions occurred on May 20, 2025, involving a significant sale and a proposed divestment by Velocity Fund Partners, LP. Prior to this, various executives and directors engaged in share acquisitions throughout 2024.
Ticker: MDCX Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.4
VELOCITY FUND PARTNERS, LP Major Shareholders
Transaction date
Proposed sale
Price
418.86
Quantity 81,403
Value US$936,529
Quinlan, James P Senior Officer of Issuer Officer
Transaction date
Purchase
Price
261.95
Quantity 17,822 -0.5%
Value US$1,367,394
Brennan, Jr., Edward Joseph Senior Officer of Issuer Officer
Transaction date
Purchase
Price
4.13
Quantity 24,242 +38.8%
Value US$99,998
Quinlan, James P Senior Officer of Issuer Officer
Transaction date
Purchase
Price
1.23
Quantity 1,245 +0.6%
Value US$1,527
Monaco, Erica Lee Senior Officer of Issuer Officer
Transaction date
Purchase
Price
1.23
Quantity 1,868 +2.5%
Value US$2,291
Lavelle, Francis W. Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
2.00
Quantity 1,245 +2.5%
Value US$2,490
Bonner, Carolyn Senior Officer of Issuer Officer
Transaction date
Purchase
Price
1.23
Quantity 311 +0.8%
Value US$381
Bokhari, Raza Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
1.23
Quantity 3,736 +0.2%
Value US$4,583
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-05-21 2025-05-20 S Sale
3.4
VELOCITY FUND PARTNERS, LP
Large shareholder
60,166 +1.9%
284.44
US$2,494,295 		60,166 +1.9% 284.44 US$2,494,295
2025-05-20 2025-05-20 PrS Proposed sale
3.4
VELOCITY FUND PARTNERS, LP

Major Shareholders
81,403
418.86
US$936,529 		81,403 418.86 US$936,529
2024-11-20 2024-11-15 B Purchase
Quinlan, James P

Senior Officer of Issuer

Officer
17,822 -0.5%
261.95
US$1,367,394 		17,822 -0.5% 261.95 US$1,367,394
2024-11-20 2024-11-15 B Purchase
Brennan, Jr., Edward Joseph

Senior Officer of Issuer

Officer
24,242 +38.8%
4.13
US$99,998 		24,242 +38.8% 4.13 US$99,998
2024-07-26 2024-06-28 B Purchase
Quinlan, James P

Senior Officer of Issuer

Officer
1,245 +0.6%
1.23
US$1,527 		1,245 +0.6% 1.23 US$1,527
2024-07-26 2024-06-28 B Purchase
Monaco, Erica Lee

Senior Officer of Issuer

Officer
1,868 +2.5%
1.23
US$2,291 		1,868 +2.5% 1.23 US$2,291
2024-07-26 2024-06-28 B Purchase
Lavelle, Francis W.

Director of Issuer

Non-Executive Director
1,245 +2.5%
2.00
US$2,490 		1,245 +2.5% 2.00 US$2,490
2024-07-26 2024-06-28 B Purchase
Bonner, Carolyn

Senior Officer of Issuer

Officer
311 +0.8%
1.23
US$381 		311 +0.8% 1.23 US$381
2024-07-26 2024-06-28 B Purchase
Bokhari, Raza

Director of Issuer, Senior Officer of Issuer

Executive Director
3,736 +0.2%
1.23
US$4,583 		3,736 +0.2% 1.23 US$4,583
Explore more

More insider trading research around Medicus Pharma Ltd

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America